Riley Jeffrey Scott has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 15000 shares of Gain Therapeutics, Inc. ($GANX) on June 24, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 24, 2025 | Gain Therapeutics, Inc. | $GANX | Riley Jeffrey Scott | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 28,685,417 | 9999.99% | 0.05% |
| June 24, 2024 | Gain Therapeutics, Inc. | $GANX | Riley Jeffrey Scott | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 17,978,951 | 9999.99% | 0.08% |
| March 28, 2024 | Gain Therapeutics, Inc. | $GANX | Riley Jeffrey Scott | Director | P | Common Stock | 30000 | $3.86 | 30,000.0000 | 13,011,361 | 9999.99% | 0.23% |
| June 23, 2023 | Gain Therapeutics, Inc. | $GANX | Riley Jeffrey Scott | Director | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 11,935,081 | 9999.99% | 0.09% |